Search

everythinglearnresearchcommunity

for

Search:↓

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Progesterone protects brain cells, but Provera does not.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Short-term side effects of low-dose radioactive iodine therapy are common but temporary.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

Caffeine reduces radiation skin damage but doesn't affect tumor treatment.

Doxorubicin causes heart damage, so early detection and monitoring are important during chemotherapy.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

The diphosphonate was the most effective at preventing calcification in rats.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.